Alvotech and dr. reddy's enter into collaboration for commercialization of avt03 (denosumab), a biosimilar candidate to prolia® & xgeva® in the u.s., europe and uk

Hyderabad, india & reykjavik, iceland--(business wire)---- $rdy #alvotech--alvotech and dr. reddy's enter into collaboration for commercialization of avt03 (denosumab), a biosimilar candidate to prolia® & xgeva®.

ALVO Ratings Summary

ALVO Quant Ranking